for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Almirall Says FDA Accepts The Filing Of The New Drug Application For Tirbanibulin

March 9 (Reuters) - Almirall SA:

* ANNOUNCES FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTANCE FOR FILING OF U.S. NEW DRUG APPLICATION (NDA) FOR TIRBANIBULIN IN ACTINIC KERATOSIS

* SAYS ESTIMATED PEAK SALES OF TIRBANIBULIN WILL BE IN EXCESS OF 250 MLN EUROS IN EUROPE AND IN THE US Source text: bit.ly/38DClwy Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up